Clinical Trials on Pharmacokinetic Interactions in United Kingdom
Total 466 results
-
University of Southern CaliforniaUniversity of California, Los AngelesActive, not recruitingCovid19 | Mental Health | Social Interaction | Housing | Physical Health | HealthcareUnited States
-
University of South CarolinaUniversity of Georgia; Oregon Research Institute; The University of QueenslandCompletedAttention Deficit Hyperactivity Disorder | Conduct Disorder | Oppositional Defiant Disorder | Childhood Disruptive Behavior Disorders | Parent-Child InteractionsUnited States
-
Astellas Pharma Global Development, Inc.CompletedRenal Impaired | Gilteritinib | Normal Renal Function | Pharmacokinetics of ASP2215United States, Bulgaria
-
Texas Tech University Health Sciences CenterUniversity of Texas Southwestern Medical Center; National Center for Research...CompletedObesity | Tuberculosis | Pharmacokinetics | MRSA | PCPUnited States
-
Food and Drug Administration (FDA)Spaulding Clinical Research LLCCompletedPharmacokinetics | Pharmacodynamics | Drug-induced QT ProlongationUnited States
-
Astellas Pharma IncAgensys, Inc.CompletedRenal Cell Carcinoma | Pharmacokinetics of AGS-16M8FUnited States
-
Food and Drug Administration (FDA)Spaulding Clinical Research LLCCompletedPharmacokinetics | Pharmacodynamics | Drug-induced QT ProlongationUnited States
-
Tabula Rasa HealthCareEnrolling by invitationCOVID | Drug Effect | Adverse Drug Event | Drug InteractionUnited States
-
Tabula Rasa HealthCareCambia Health SolutionsEnrolling by invitationCOVID | Drug Effect | Adverse Drug Event | Drug InteractionUnited States
-
University of Colorado, DenverBristol-Myers Squibb; The Miriam Hospital; University of WashingtonCompletedHIV Infections | Contraception | PharmacokineticsUnited States
-
CytokineticsCompletedChronic Heart Failure | Pharmacokinetics | Left Ventricular Systolic Dysfunction | Left Ventricular Ejection Fraction | Modified Release Oral Formulation | History of Chronic Heart Failure | EchocardiogramUnited States, Canada, Italy, Netherlands, United Kingdom, Belgium, Czechia, Australia, Hungary, Poland, Bulgaria, Lithuania, Germany
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell Lung | Solid Tumor | Pharmacokinetics | Triple Negative Breast NeoplasmsUnited States, Chile, Israel, Korea, Republic of, Netherlands, Spain, Taiwan
-
Walter K. KraftMerck Sharp & Dohme LLCCompletedLatent Tuberculosis | Human Immunodeficiency Virus | Drug Interaction Potentiation | Rifamycins Causing Adverse Effects in Therapeutic UseUnited States
-
Genelex CorporationHarding UniversityCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme... and other conditionsUnited States
-
Genelex CorporationUniversity of UtahCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme Deficiency | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome... and other conditionsUnited States